Stocks closed only marginally lower on Tuesday, but investors bought the dips and the investment community has proven daily, weekly and monthly now for almost 4 years that they will buy stocks on any weakness. It seems that investors are looking for value and other less-discovered avenues for growth and profits ahead.
24/7 Wall St. reviews dozens of analyst research reports each morning of the week, and we revisit the impact calls each day and each week to which calls stood out. Some of these calls were missed this morning in the preliminary analyst calls, but the real focus here was on key analyst calls which seemed very impacting when made and were largely overlooked or discounted by the investing community’s reaction.
Tuesday’s preliminary top analyst upgrades and downgrades included shares of Bluebird Bio, Boston Beer, Etsy, Gilead, Pfizer, PMC-Sierra, Valeant and over a dozen more. Here are five more key analyst upgrades or positive research calls which were overlooked or discounted this Tuesday.
Alibaba Group Holding Ltd. (NYSE: BABA) may not seem like much when you hear it, but when was the last time you saw a price target get hiked in the Chinese online seller of anything? Evercore ISI already rates Alibaba as Buy, but it raised the price target to $88.00 from $86.00 in the call. Alibaba shares were down 1.2% at $71.75 right before the close, versus a consensus analyst target of $90.50 and versus a 52-week range of $57.20 to $120.00.
Bluebird Bio, Inc. (NASDAQ: BLUE) was given a ‘double your money’ research call on Tuesday. Oppenheimer started coverage with an Outperform rating and assigned a $162.00 price target after noting that sell-off has gone too far versus the opportunity here. Bluebird has a $200 or so consensus target price, and the $80.35 price at the end of Tuesday was down 1.8% right before the close. Bluebird has a 52-week range of $35.00 to $197.35.
Clean Diesel Technologies Inc. (NASDAQ: CDTI) was started as Buy at Rodman & Renshaw and H.C. Wainwright on Tuesday, and the $3.00 price targets implied upside of roughly 80% from the prior $1.61 close. Clean Diesel may have suffered by its name having the word “diesel” in its title, with a 52-week range of $1.45 to $3.97. This was almost $2.00 just a month ago.
Facebook, Inc. (NASDAQ: FB) was down on Tuesday by 1.5% at $97.00, but Jefferies reiterated its Buy rating while raising its price target to $130.00 from $120.00 in the call. A higher price target is justified here over potential video advertisements and Instagram becoming the next billion-dollar business for Facebook. Jefferies sees Facebook and Google’s YouTube taking the bulk of what may be a $17 billion total market opportunity. Facebook has a consensus price target of about $112.50 and a 52-week range of $72.00 to $99.59. This may not have been the best target on Wall Street, but it is well above average.
Hawaiian Holdings Inc. (NASDAQ: HA) managed to beat earnings estimates with a $70 million profit in its third quarter. The stock rose only by 1.2% to $31.37, a very muted reaction, and that is very weak against the three price targets we saw on Tuesday. Hawaiian Holdings saw Cowen & Co. raise its target to $31 from $26, Sterne Agee CRT raise its target to $43 from $37, and Deutsche Bank raise its target to $37 from $30. Maybe this is because shares hit a 52-week high of $31.64. Still, the response feels muted for three action calls and stronger earnings.
Travel Cards Are Getting Too Good To Ignore (sponsored)
Credit card companies are pulling out all the stops, with the issuers are offering insane travel rewards and perks.
We’re talking huge sign-up bonuses, points on every purchase, and benefits like lounge access, travel credits, and free hotel nights. For travelers, these rewards can add up to thousands of dollars in flights, upgrades, and luxury experiences every year.
It’s like getting paid to travel — and it’s available to qualified borrowers who know where to look.
We’ve rounded up some of the best travel credit cards on the market. Click here to see the list. Don’t miss these offers — they won’t be this good forever.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.